Glomerular albumin filtration through podocyte cell body in puromycin aminonucleoside nephrotic rat

被引:0
|
作者
Akihiro Tojo
Maristela Lika Onozato
Chagriya Kitiyakara
Satoshi Kinugasa
Satoru Fukuda
Toshio Sakai
Toshiro Fujita
机构
[1] University of Tokyo,Division of Nephrology and Endocrinology
[2] Georgetown University,Division of Nephrology and Hypertension, Cardiovascular Kidney Institute
[3] Mahidol University,Renal Division, Ramathibodi Hospital
[4] Electron Microscope Application Laboratory,undefined
来源
Medical Molecular Morphology | 2008年 / 41卷
关键词
Albumin; Glomerular filtration; Slit membrane; Nephrotic syndrome; Proteinuria; Podocyte;
D O I
暂无
中图分类号
学科分类号
摘要
It is an a priori concept that protein molecules including albumin are filtrated through the slit membrane between the foot processes of podocytes. However, foot processes are effaced and the number of slit membranes is reduced in nephrotic syndrome, suggesting another pathway of albumin filtration through the foot process cell body. Thus, we investigated the pathway of gold-and fluorescein isothiocyanate (FITC)-labeled albumin filtration in the puromycin aminonucleoside (PAN) model of nephrotic syndrome in the rat. PAN rats at day 7 with established nephrotic proteinuria were injected with 8-nm gold-labeled albumin and FITC-labeled albumin through the jugular vein followed by kidney fixation at 10 or 30 min. Goldlabeled albumin was accumulated in the paramesangial area and in the endosomes of glomerular endothelial cells of both control and PAN rats by electron microscopy. On the other hand, FITC-labeled albumin was detected between foot processes in the control but more in the podocyte cell body in the PAN rat. In conclusion, albumin will be filtrated through the decreased numbers of slit diaphragms; however, albumin can be also taken up in the podocyte, the mesangium, and the glomerular endothelium, suggesting that there might be other routes of glomerular albumin clearance in nephrotic syndrome.
引用
收藏
页码:92 / 98
页数:6
相关论文
共 50 条
  • [21] PUROMYCIN AMINONUCLEOSIDE NEPHROPATHY - ULTRASTRUCTURE, GLOMERULAR POLYANION, AND CELL-SURFACE MARKERS
    ROSSMANN, P
    BUKOVSKY, A
    MATOUSOVIC, K
    HOLUB, M
    KRAL, J
    JOURNAL OF PATHOLOGY, 1986, 148 (04): : 337 - 348
  • [22] Protection of α3 integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat
    Kojima, K
    Matsui, K
    Nagase, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) : 1175 - 1185
  • [23] SERUM PHOSPHOLIPID ALTERATIONS AND THEIR CONTROL BY CHLOROPHENOXYISOBUTYRATE AND BETABENZALBUTYRATE IN PUROMYCIN AMINONUCLEOSIDE INDUCED NEPHROTIC SYNDROME IN RAT
    GALLI, C
    EDWARDS, KDG
    PAOLETTI, R
    LIFE SCIENCES PT-2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1970, 9 (09): : 523 - +
  • [24] PLASMA AND URINARY LIPIDS AND LIPOPROTEINS DURING THE DEVELOPMENT OF NEPHROTIC SYNDROME INDUCED IN THE RAT BY PUROMYCIN AMINONUCLEOSIDE
    GHERARDI, E
    CALANDRA, S
    BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 710 (02) : 188 - 196
  • [25] Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases
    Dong, Nan
    Meng, Lixia
    Xue, Ruqun
    Yu, Meng
    Zhao, Zhonghua
    Liu, Xueguang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (08) : 1489 - 1506
  • [26] Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases
    Nan Dong
    Lixia Meng
    Ruqun Xue
    Meng Yu
    Zhonghua Zhao
    Xueguang Liu
    International Urology and Nephrology, 2017, 49 : 1489 - 1506
  • [27] Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
    Tadashi Okada
    Toshifumi Sakaguchi
    Ikuji Hatamura
    Fumie Saji
    Shigeo Negi
    Haruhisa Otani
    Yasuteru Muragaki
    Hiroshi Kawachi
    Takashi Shigematsu
    Clinical and Experimental Nephrology, 2009, 13 : 438 - 446
  • [28] Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
    Okada, Tadashi
    Sakaguchi, Toshifumi
    Hatamura, Ikuji
    Saji, Fumie
    Negi, Shigeo
    Otani, Haruhisa
    Muragaki, Yasuteru
    Kawachi, Hiroshi
    Shigematsu, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (05) : 438 - 446
  • [29] DEVELOPMENT OF A RAT GLOMERULAR CULTURE SYSTEM - EFFECTS OF PUROMYCIN AMINONUCLEOSIDE (PAN) ON PODOCYTIC EPITHELIUM INVITRO
    DILLANE, PC
    RYAN, GB
    JOURNAL OF ANATOMY, 1986, 149 : 260 - 261
  • [30] Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase
    Kinugasa, Satoshi
    Tojo, Akihiro
    Sakai, Tatsuo
    Tsumura, Harukuni
    Takahashi, Masafumi
    Hirata, Yasunobu
    Fujita, Toshiro
    KIDNEY INTERNATIONAL, 2011, 80 (12) : 1328 - 1338